Shaanxi LvYuan Biopharmaceutical Co., Ltd. was established on November 24, 201, with Feng Zhongde as its legal representative, the unified social credit code is 91610131MA7CJ27W6G the registered capital is 10 million RMB, and the registered address of the company is located at No.16, Biomedical Industry R&D Agglomeration, No.10 Building, Caotang Fourth Road, High-tech Zone, Xi'an, Shaanxi Province. The business scope includes: general items: sales new catalytic materials and auxiliaries; sales of electronic specialty materials; research and development of new material technology; research and development of bio-based material technology; natural science research experimental development; research and development of biochemical product technology; promotion services of new material technology; production of chemical products (excluding licensed chemical products); manufacturing of specialty chemical productsexcluding hazardous chemicals); manufacturing of medical packaging materials; technology services, technology development, technology consultation, technology exchange, technology transfer, technology promotion; import and export of goods; import export of technology.
The company adheres to the corporate philosophy of customer first, technology to revitalize the enterprise, backbone holding shares, and green development. The company headquarters covers area of 3,000 square meters and is equipped with R&D facilities and equipment such as laboratories, analysis rooms, and pilot production workshops. It has more than 20 professional talents with more than ten years of work experience, more than 40 experienced technical workers, and has a production workshop of 2,600 square in Shaanxi, with 32 sets of main production equipment, and has the ability to achieve industrial scale. The company is committed to the research and development of high- products such as biopharmaceuticals, functional agriculture, and organic electro-luminescent materials. The products have the characteristics of high precision, green environmental protection, and to national strategic planning.
